SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

M Lipsitch, F Krammer, G Regev-Yochay… - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …

COVID-19 2022 update: transition of the pandemic to the endemic phase

M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …

[HTML][HTML] COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron …

AG Johnson - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
In 25 US jurisdictions, decreases in case incidence rate ratios for unvaccinated versus fully
vaccinated persons with and without booster vaccine doses were observed when the …

Covid-19 vaccine effectiveness in New York state

ES Rosenberg, V Dorabawila, D Easton… - … England Journal of …, 2022 - Mass Medical Soc
Background Population-based data from the United States on the effectiveness of the three
coronavirus disease 2019 (Covid-19) vaccines currently authorized by the Food and Drug …

SARS-CoV-2 vaccine protection and deaths among US veterans during 2021

BA Cohn, PM Cirillo, CC Murphy, NY Krigbaum… - Science, 2022 - science.org
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

JP Evans, C Zeng, C Carlin, G Lozanski… - Science Translational …, 2022 - science.org
The waning efficacy of SARS-CoV-2 vaccines, combined with the continued emergence of
variants resistant to vaccine-induced immunity, has reignited debate over the need for …

Public health impact of covid-19 vaccines in the US: observational study

AB Suthar, J Wang, V Seffren, RE Wiegand, S Griffing… - Bmj, 2022 - bmj.com
Objective To evaluate the impact of vaccine scale-up on population level covid-19 mortality
and incidence in the United States. Design Observational study. Setting US county level …

[HTML][HTML] Risk factors for severe COVID-19 outcomes among persons aged≥ 18 years who completed a primary COVID-19 vaccination series—465 health care …

C Yek - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Among 1,228,664 persons who completed primary vaccination during December 2020–
October 2021, severe COVID-19–associated outcomes (0.015%) or death (0.0033%) were …

[HTML][HTML] Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2

JP Evans, C Zeng, P Qu, J Faraone, YM Zheng… - Cell host & …, 2022 - cell.com
Recent reports of SARS-CoV-2 Omicron variant sub-lineages, BA. 1, BA. 1.1, and BA. 2,
have reignited concern over potential escape from vaccine-and infection-induced immunity …

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo… - bmj, 2021 - bmj.com
Objectives To evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2
variants and assess its effectiveness against the delta variant by time since vaccination …